Gao Liu

Senior Scientist at RubrYc Therapeutics, Inc.
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
San Francisco Bay Area
Languages
  • English -
  • Chinese -
Skills

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
Join now
You need to have a working account to view this content.
Join now

Experience

  • RubrYc Therapeutics, Inc.
    • United States
    • Biotechnology Research
    • 1 - 100 Employee
    • Senior Scientist
      • Oct 2021 - Present

  • Denali Therapeutics
    • United States
    • Biotechnology Research
    • 200 - 300 Employee
    • Scientist, Antibody Discovery
      • Nov 2019 - Sep 2021

  • 23andMe
    • United States
    • Biotechnology Research
    • 400 - 500 Employee
    • Sr. Scientific Researcher
      • Sep 2017 - Dec 2019

  • Astellas Pharma US
    • United States
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Senior Principal Research Associate
      • Mar 2009 - Sep 2017

  • FACET Facade Consultancy Pvt. Ltd
    • India
    • Design
    • 1 - 100 Employee
    • Scientist I
      • Dec 2008 - Mar 2009

      Therapeutic and reagent mAb development Therapeutic and reagent mAb development

  • PDL BioPharma
    • Biotechnology Research
    • 200 - 300 Employee
    • Senior RA/ Associate Scientist /Scientist I
      • Apr 1996 - Nov 2008

      Therapeutic and Reagent Antibody generation and characterization Antibody based assay development Monoclonal antibody applications development Hybridoma technology development Inventor for anti-human CS1 Anbody Luc63 and LucX ( one US patent and one international patent ) Inventor for CCR5 mAbs, Amphiregulin mAbs, IP-10 mAbs and other mAbs against human cancer or autoimmune targets Therapeutic and Reagent Antibody generation and characterization Antibody based assay development Monoclonal antibody applications development Hybridoma technology development Inventor for anti-human CS1 Anbody Luc63 and LucX ( one US patent and one international patent ) Inventor for CCR5 mAbs, Amphiregulin mAbs, IP-10 mAbs and other mAbs against human cancer or autoimmune targets

  • Systemix Inc ( Novartis now defunct )
    • San Francisco Bay Area
    • Senior RA II
      • Sep 1994 - Apr 1996

      Animal immunization, hybridoma generation, mAb screen and characterization. Stem cell research Animal immunization, hybridoma generation, mAb screen and characterization. Stem cell research

  • National Cancer Institute (NCI)
    • United States
    • Research Services
    • 700 & Above Employee
    • Visiting Fellow
      • Mar 1989 - Apr 1994

      Cancer and HIV research Cancer and HIV research

Education

  • Fudan University
    Master, Biochemisry and Immunology
    1983 - 1985

Community

You need to have a working account to view this content. Click here to join now